TMCnet News
Prevail Therapeutics to Present at Morgan Stanley 2019 Global Healthcare ConferenceNEW YORK, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Prevail Therapeutics Inc. (Nasdaq: PRVL) (“Prevail” or “the Company”), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with neurodegenerative disorders, today announced that Asa Abeliovich, M.D., Ph.D., Founder and Chief Executive Officer, will present at the Morgan Stanley 2019 Global Healthcare Conference on Wednesday, September 11, 2019 at 1:00 p.m. ET in New York City. The live webcast will be available in the investor section of the company's website at www.prevailtherapeutics.com. The webcast will be archived for 90 days following the presentation. About Prevail Therapeutics Media Contact: Katie Engleman 1AB [email protected] Investor Contact: [email protected] |